FTSE All-Share
5.597,04
PKT
-52,65
PKT
-0,93
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08:16 | Rio Tinto Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.06.26 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 16.06.26 | BP Buy | UBS AG | |
| 16.06.26 | National Grid Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.06.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 15.06.26 | National Grid Outperform | Bernstein Research | |
| 15.06.26 | GSK Neutral | UBS AG | |
| 15.06.26 | Vodafone Group Buy | Deutsche Bank AG | |
| 15.06.26 | London Stock Exchange (LSE) Buy | Goldman Sachs Group Inc. | |
| 11.06.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 11.06.26 | BP Outperform | RBC Capital Markets | |
| 11.06.26 | Vodafone Group Equal Weight | Barclays Capital | |
| 10.06.26 | GSK Hold | Deutsche Bank AG | |
| 10.06.26 | Unilever Overweight | Barclays Capital | |
| 10.06.26 | BP Neutral | JP Morgan Chase & Co. | |
| 10.06.26 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 10.06.26 | GSK Neutral | UBS AG | |
| 09.06.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 09.06.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 09.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.06.26 | GSK Neutral | UBS AG | |
| 09.06.26 | GSK Underweight | Barclays Capital | |
| 09.06.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 09.06.26 | GSK Hold | Deutsche Bank AG | |
| 09.06.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 09.06.26 | BAT Buy | Jefferies & Company Inc. | |
| 08.06.26 | GSK Hold | Deutsche Bank AG | |
| 08.06.26 | National Grid Hold | Deutsche Bank AG | |
| 08.06.26 | Diageo Buy | Jefferies & Company Inc. | |
| 05.06.26 | Diageo Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.06.26 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 05.06.26 | BP Neutral | JP Morgan Chase & Co. | |
| 04.06.26 | GSK Buy | Jefferies & Company Inc. | |
| 03.06.26 | Rio Tinto Underperform | RBC Capital Markets | |
| 02.06.26 | Unilever Outperform | Bernstein Research | |
| 02.06.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 02.06.26 | BAT Buy | Jefferies & Company Inc. | |
| 02.06.26 | BAT Underperform | RBC Capital Markets | |
| 02.06.26 | GSK Hold | Deutsche Bank AG | |
| 02.06.26 | Rio Tinto Hold | Deutsche Bank AG |